عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.
Download the new version of the MOPH app 
for the latest updates on Coronavirus
 
Be Responsible
#Raise your voice
Send us any Fraudulent Action or Enquiry so we can ALL contribute to make a Difference

Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
 
You can search in the form below for information related to drugs including Subsidy percentage

​Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
 
    1
    ...
    3
    4
    5
    6
    7
    8
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
L01XX24 ONCASPAR B Pegaspargase - 750U/ml 750U/ml Injectable powder for solution 2,833,661 L.L
A02BC01 OMEPRAZOLE ARROW G Omeprazole - 40mg 40mg Injectable powder for solution 454,219 L.L
L01XX24 ONCASPAR B Pegaspargase - 750U/ml 750U/ml Injectable powder for solution 172,758,585 L.L
L01XA03 OXALIPLATIN MEDAC G Oxaliplatin - 100mg 100mg Injectable powder for solution 7,841,801 L.L
L01XA03 OXALIPLATINE VIATRIS 5MG/ML G Oxaliplatin - 100mg 100mg Injectable powder for solution 6,728,802 L.L
L01XA03 OXALIPLATIN MEDAC G Oxaliplatin - 50mg 50mg Injectable powder for solution 3,440,237 L.L
L01XA03 OXALIPLATINE VIATRIS 5MG/ML G Oxaliplatin - 50mg 50mg Injectable powder for solution 4,135,003 L.L
B02BD02 OCTANATE BioHuman Coagulation Factor VIII - 250IU 250IU Injectable lyophilised powder for solution+diluent 4,425,571 L.L
B02BD02 OCTANATE BioHuman Coagulation Factor VIII - 500IU 500IU Injectable lyophilised powder for solution+diluent 11,057,052 L.L
B02BD02 OCTANATE BioHuman Coagulation Factor VIII - 1,000IU 1,000IU Injectable lyophilised powder for solution+diluent 15,640,710 L.L
L01XA03 OXALIPLATINO GP PHARM G Oxaliplatin - 100mg 100mg Injectable lyophilised powder for solution 6,199,145 L.L
L01XA03 OXALTIE G Oxaliplatin - 100mg 100mg Injectable lyophilised powder for solution 5,915,595 L.L
L01XA03 OXALIPLATINO GP PHARM G Oxaliplatin - 50mg 50mg Injectable lyophilised powder for solution 2,957,797 L.L
L01XA03 OXALTIE G Oxaliplatin - 50mg 50mg Injectable lyophilised powder for solution 2,957,797 L.L
L01FD01 OGIVRI BioTech Trastuzumab - 440mg 440mg Injectable lyophilised powder 80,027,615 L.L
L01FD01 OGIVRI BioTech Trastuzumab - 440mg 440mg Injectable lyophilised powder 80,027,615 L.L
L01XA03 OXALTIE G Oxaliplatin - 50mg 50mg Injectable lyophilised powder 2,957,797 L.L
B02BD04 OCTANINE F BioHuman Plasma coagulation factor IX, human - 500IU 500IU Injectable freeze dried powder + diluent 13,114,263 L.L
B05BA10 OLIMEL N9E B Glucose solution - 27.5%, Amino acids solution - 14.2%, Lipid emulsion - 20%, Sodium - 70mmol/2l, Potassium - 60mmol/2l, Magnesium - 8mmol/2l, Calcium - 7mmol/2l, Phosphate - 30mmol/2l, Acetate - 107mmol/2l, Chloride - 90mmol/2l, Azote - 18g/2l Injectable emulsion 5,495,980 L.L
B05BA10 OLIMEL N9 B Glucose solution - 27.5%, Amino acids solution - 14.2%, Lipid emulsion - 20%, Azote - 9g/l Injectable emulsion 5,630,028 L.L
B05BA10 OLIMEL N9E B Glucose solution - 27.5%, Amino acids solution - 14.2%, Lipid emulsion - 20%, Sodium - 35mmol/l, Potassium - 30mmol/l, Magnesium - 4mmol/l, Calcium - 3.5mmol/l, Phosphate - 15mmol/l, Acetate - 54mmol/l, Chloride - 45mmol/l, Azote - 9g/l Injectable emulsion 4,101,878 L.L
B05BA10 OLIMEL N7E B Glucose solution - 35%, Amino acids solution - 11.1%, Lipid emulsion - 20%, Sodium - 35mmol/l, Potassium - 30mmol/l, Magnesium - 4mmol/l, Calcium - 3.5mmol/l, Phosphate - 15mmol/l, Acetate - 45mmol/l, Chloride - 45mmol/l, Azote - 7g/l Injectable emulsion 4,101,878 L.L
B05BA10 OLIMEL N7E B Glucose solution - 35%, Amino acids solution - 11.1%, Lipid emulsion - 20%, Sodium - 70mmol/2l, Potassium - 60mmol/2l, Magnesium - 8mmol/2l, Calcium - 7mmol/2l, Phosphate - 30mmol/2l, Acetate - 89mmol/2l, Chloride - 90mmol/2l, Azote - 14g/2l Injectable emulsion 5,456,471 L.L
B05BA10 OLICLINOMEL N4-550E B Chlorure de Calcium - 80g/l, Chlorure de Magnesium - 0.45g/l, Chlorure de Potassium - 1.19g/l, Glycérophosphate de Sodium.5H2O - 2.14g/l, Acétate de Sodium.3H2O - 0.98g/l, Valine - 1.28g/l, Tyrosine - 0.09g/l, Tryptophan - 0.4g/l, Threonine - 0.92g/l, Serine - 1.1g/l, Proline - 1.5g/l, Phenylalanine - 1.23g/l, Methionine - 0.88g/l, Lysine - 1.28g/l, Leucine - 1.61g/l, Isoleucine - 1.32g/l, Histidine - 1.06g/l, Glycine - 2.27g/l, Arginine - 2.53g/l, Alanine - 4.56g/l, Huile D'olive + huile De soja purifées - 20g/l 2.2% Injectable emulsion 4,043,622 L.L
B05BA10 OLICLINOMEL N7-1000E B Chlorure de Calcium - 160g/l, Chlorure de Magnesium - 0.45g/l, Chlorure de Potassium - 1.79g/l, Glycérophosphate de Sodium.5H2O - 2.14g/l, Acétate de Sodium.3H2O - 2.45g/l, Valine - 2.32g/l, Tyrosine - 0.16g/l, Tryptophan - 0.72g/l, Threonine - 1.68g/l, Serine - 2g/l, Proline - 2.72g/l, Phenylalanine - 2.24g/l, Methionine - 1.6g/l, Lysine - 2.32g/l, Leucine - 2.92g/l, Isoleucine - 2.4g/l, Histidine - 1.92g/l, Glycine - 4.12g/l, Arginine - 4.6g/l, Alanine - 8.28g/l, Huile D'olive + huile De soja purifées - 40g/l 4% Injectable emulsion 5,709,046 L.L
L01XA03 OXALIPLATIN HOSPIRA G Oxaliplatin - 100mg/20ml 5mg/ml Injectable concentrated solution 8,200,848 L.L
L01XA03 OXALIPLATIN EBEWE G Oxaliplatin - 50mg/10ml 50mg/10ml Injectable concentrated solution 3,405,297 L.L
L01XA03 OXALIPLATIN HOSPIRA G Oxaliplatin - 50mg/10ml 5mg/ml Injectable concentrated solution 3,450,988 L.L
L04AA36 OCREVUS BioTech Ocrelizumab - 300mg/10ml 300mg/10ml Injectable concentrate for solution 8,980,617 L.L
L04AA36 OCREVUS BioTech Ocrelizumab - 300mg/10ml 300mg/10ml Injectable concentrate for solution 547,517,314 L.L
    1
    ...
    3
    4
    5
    6
    7
    8
Sitemap
© Copyrights reserved to Ministry of Public Health 2024